ERM US 101 – Sponsored by Notal Vision, Inc.

Completed Study | Duration: 12 Months

ERM US 101 was conducted to compare the output of the ForeseeHome device in detecting and monitoring metamorphopsia (distortion) due to an epiretinal membrane (ERM). The study also worked to predict the degree of distortion following surgery. The device is currently FDA approved to monitor the development of choroidal neovascularization in patients with wet AMD. This study was for patients 21 years of age and older with a diagnosis of epiretinal membrane.

Return to Other Eye Diseases


Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC ERM US 101 Study | ERM Treatment in Maryland | Virginia ERM US 101 Study